Upside case
Bull case
$216+122.4%
CCEP would need investors to value it at roughly 49x earnings — about 27x more generous than today's 22x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Analysis OverviewBuyUpdated Jun 18, 2026
Coca-Cola Europacific Partners PLC (CCEP) Stock Analysis
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Analyst consensus
Buy
Covering
28
analysts
15 bullish · 2 bearish · 28 covering CCEP
Strong Buy
0
Buy
15
Hold
11
Sell
2
Strong Sell
0
Consensus Target
$111
+14.0% vs today
Scenario Range
$103 – $216
Model bear to bull value window
Coverage
28
Published analyst ratings
Valuation Context
21.8x
Forward P/E · Market cap $43.5B
CCEP price targets
Three scenarios for where CCEP stock could go
Current
~$97
Confidence
44 / 100
Updated
Jun 18, 2026
Where we are now
Current · $97
Bear
$103
Base
$164
Bull
$216
Market caseClosest to today
Base case
$164+68.8%
At 37x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
Stress case
Bear case
$103+6.3%
The bear case assumes sentiment or fundamentals disappoint enough to push CCEP down roughly 6% from the current price.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.
Coca-Cola Europacific Partners PLC
CCEP · NASDAQConsumer DefensiveBeverages - Non-AlcoholicDecember year-end
Coca-Cola Europacific Partners is a major Coca-Cola bottling partner that produces, distributes, and sells non-alcoholic beverages across Europe and the Asia-Pacific region. It generates revenue primarily through beverage sales — including sparkling drinks (~60%), still beverages (~30%), and energy drinks (~10%) — with most coming from its core Coca-Cola brand portfolio. Its key advantage is exclusive long-term bottling rights for Coca-Cola products in its territories, combined with extensive distribution networks and local market expertise.
Market Cap
$43.5B
Revenue TTM
$41.3B
Net Income TTM
$3.4B
Net Margin
8.1%
CCEP Revenue and Earnings Performance
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
EPS Beat Rate
75%Exceptional
12 quarters tracked
Revenue Beat Rate
50%Exceptional
vs consensus estimates
Avg EPS Surprise
+1.9%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q4 2024
Q1 2025
Q3 2025
Q1 2026
Last 4 Quarters
EPS beats: 3 of 4Q4 2024
EPS
$2.11/$2.05
Revenue
$10.6B/$10.7B
Q1 2025
EPS
$2.05/$2.03
Revenue
$11.1B/$11.0B
Q3 2025
EPS
$2.38/$2.41
Revenue
$12.0B/$12.1B
Q1 2026
EPS
$2.45/$2.40
Revenue
$12.5B/$12.5B
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q4 2024 | $2.11/$2.05 | +2.9% | $10.6B/$10.7B | -1.4% |
| Q1 2025 | $2.05/$2.03 | +1.0% | $11.1B/$11.0B | +1.0% |
| Q3 2025 | $2.38/$2.41 | -1.2% | $12.0B/$12.1B | -0.6% |
| Q1 2026 | $2.45/$2.40 | +2.1% | $12.5B/$12.5B | -0.5% |
FY1–FY2 Estimates
Revenue Outlook
FY1
$42.7B
+3.5% YoY
FY2
$44.0B
+3.1% YoY
EPS Outlook
FY1
$7.36
-1.4% YoY
FY2
$7.82
+6.2% YoY
Trailing FCF (TTM)$4.4B
FCF Margin: 10.7%
Next Earnings
August 4, 2026
Expected EPS
$2.46
Expected Revenue
$12.3B
CCEP beat EPS estimates in 3 of 4 tracked quarters. A strong delivery record supports forward estimate credibility.
CCEP Revenue Breakdown by Segment
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest disclosure
FY 2024
Total disclosed revenue $34.3B
Product Mix
Latest annual revenue by segment or product family
Segment breakdown not available for this company.
Geographic Mix
Latest annual revenue by reported region
Europe
43.6%
+2.9% YoY
Tap, hover, or focus a slice to inspect segment detail.
Europe is the largest reported region at 43.6%, up 2.9% YoY.
CCEP Valuation Snapshot
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Relative Value Signal
Cheap versus peers
Fair value est. $138 — implies +42.7% from today's price.
Upside to Fair Value
42.7%
potential upside
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
CCEP
20.6x
vs
S&P 500
24.4x
16% discount
vs Consumer Defensive Trailing P/E
CCEP
20.6x
vs
Consumer Defensive
18.9x
+9% premium
vs CCEP 5Y Avg P/E
Today
20.6x
vs
5Y Average
21.7x
In line with benchmark
Forward PE
21.8x
S&P 500
18.8x
+16%
Consumer Defensive
14.2x
+54%
5Y Avg
—
—
Trailing PE
20.6x
S&P 500
24.4x
-16%
Consumer Defensive
18.9x
+9%
5Y Avg
21.7x
-5%
PEG Ratio
0.68x
S&P 500
1.66x
-59%
Consumer Defensive
1.92x
-65%
5Y Avg
—
—
EV/EBITDA
13.9x
S&P 500
15.2x
-9%
Consumer Defensive
11.1x
+25%
5Y Avg
14.6x
-5%
Price/FCF
19.4x
S&P 500
20.7x
-6%
Consumer Defensive
15.3x
+27%
5Y Avg
15.3x
+27%
Price/Sales
1.9x
S&P 500
3.1x
-39%
Consumer Defensive
0.9x
+114%
5Y Avg
1.8x
+7%
Dividend Yield
2.32%
S&P 500
1.91%
+21%
Consumer Defensive
3.06%
-24%
5Y Avg
2.60%
-11%
| Metric | CCEP | S&P 500 | Consumer Defensive | 5Y Avg CCEP |
|---|---|---|---|---|
| Forward PE | 21.8x | 18.8x+16% | 14.2x+54% | — |
| Trailing PE | 20.6x | 24.4x-16% | 18.9x | 21.7x |
| PEG Ratio | 0.68x | 1.66x-59% | 1.92x-65% | — |
| EV/EBITDA | 13.9x | 15.2x | 11.1x+25% | 14.6x |
| Price/FCF | 19.4x | 20.7x | 15.3x+27% | 15.3x+27% |
| Price/Sales | 1.9x | 3.1x-39% | 0.9x+114% | 1.8x |
| Dividend Yield | 2.32% | 1.91% | 3.06% | 2.60% |
CCEP trades above S&P 500 benchmarks on 1 of 6 measured multiples — appears modestly priced relative to the S&P 500 on most measures.
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolCCEP Financial Health
Verdict
Strong
CCEP generates $4.4B in free cash flow at a 10.7% margin — 10.4% ROIC signals a durable competitive advantage · returns 5.0% of market cap to shareholders annually.
Cash Engine
Revenue, margins, and cash generation
Revenue (TTM)
Trailing-twelve-month sales base
$41.3B
Revenue Growth
TTM vs prior year
+14.7%
Gross Margin
Gross profit as a share of revenue
35.4%
Operating Margin
Operating income divided by revenue
11.7%
Net Margin
Net income divided by revenue
8.1%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$7.46
Free Cash Flow (TTM)
Cash generation after capex
$4.4B
FCF Margin
FCF as share of revenue — the primary cash quality signal
10.7%
Capital Quality
ROIC, leverage, and debt serviceability
ROIC
Return on invested capital — primary competitive quality signal
10.4%
ROA
Return on assets, trailing twelve months
11.2%
Cash & Equivalents
Liquid assets on the balance sheet
$918M
Net Debt
Total debt minus cash
$10.3B
Debt Serviceability
Net debt as a multiple of annual free cash flow
2.3× FCF
~2.3 years to full repayment at current FCF run-rate
ROE *
Return on equity, trailing twelve months
40.4%
* Elevated by buyback-compressed equity — compare ROIC (10.4%) for an undistorted picture of capital efficiency.
Shareholder Returns
How capital is returned to owners
Total shareholder yield
5.0%
Dividend
2.3%
Buyback
2.7%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$1.0B
Dividend / Share
Annualized trailing dividend per share
$1.95
Payout Ratio
Share of earnings distributed as dividends
47.7%
Shares Outstanding
Declining as buybacks retire shares
449M
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt). ROE marked * where buyback-compressed equity base may inflate the figure.
Open full ratios pageCCEP Stock Risk Factors
Key factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 18, 2026
Medium
Revenue growth uncertainty
Revenue expansion of 3%-4% is contingent on premiumization and innovation, which may not materialize as expected.
High Risk
Forward-looking statement risks
Financial projections and strategic objectives are subject to uncertainties, including mergers, acquisitions, and market conditions.
Lower
Brand association risks
Potential negative associations with unrelated terms like 'coca' could marginally impact brand perception.
Medium
Dependence on Coca-Cola partnership
Innovation pipelines and growth heavily rely on the partnership with The Coca-Cola Company, introducing dependency risks.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Why CCEP Stock Could Outperform
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 18, 2026
Revenue and profit growth
FY2025 revenue reached €20.9bn, up 2.8%, with comparable operating profit rising 7.1% and operating margin expanding to 13.4%.
Strong cash flow generation
The business continues to generate significant free cash flow, with €1.8bn reported, indicating robust financial health.
Market share expansion
Coca-Cola Europacific Partners is growing its share ahead of the market, as evidenced by strong Q1 2026 trading updates.
Geographic diversification
The company operates across 31 markets, with a balanced revenue split between Europe (71%) and Asia-Pacific (29%).
Franchised bottler advantage
As the world's largest Coca-Cola bottler, CCEP benefits from manufacturing, distributing, and merchandising Coca-Cola's branded beverages globally.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
CCEP Stock Price Performance
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Current Price
$96.93
52W Range Position
47%
52-Week Range
Current price plotted between the 52-week low and high.
52-Week Low
$84.66
+14.5% from the low
52-Week High
$110.90
-12.6% from the high
1 Month
+4.89%
3 Month
+0.88%
YTD
+9.9%
1 Year
+4.6%
3Y CAGR
+14.1%
5Y CAGR
+9.5%
10Y CAGR
+9.9%
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
CCEP vs Peers
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
Peer Set
Accurate peer set
Forward PE
21.8x
vs 18.7x median
+16% above peer median
Revenue Growth
+3.5%
vs +4.6% median
-24% below peer median
Net Margin
8.1%
vs 15.6% median
-48% below peer median
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
CCE CCEP Coca-Cola Europacific Partners PLC | $43.5B | 21.8x | +3.5% | 8.1% | Buy | +14.0% |
KO KO The Coca-Cola Company | $341.7B | 24.3x | +2.7% | 27.8% | Buy | +8.5% |
PEP PEP PepsiCo, Inc. | $194.1B | 16.4x | +4.6% | 8.8% | Hold | +18.2% |
MNS MNST Monster Beverage Corporation | $89.3B | 39.9x | +9.4% | 23.1% | Buy | -0.8% |
FIZ FIZZ National Beverage Corp. | $3.4B | 18.1x | +2.4% | 15.6% | Sell | -6.3% |
CEL CELH Celsius Holdings, Inc. | $7.9B | 18.7x | +11.4% | 5.9% | Buy | +71.5% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
CCEP Dividend and Capital Return
CCEP returns 5.0% annually — 2.32% through dividends and 2.7% through buybacks.
Dividend SustainableFCF Well Covered
Total Shareholder Yield
5.0%
Dividend + buyback return per year
Buyback Yield
2.7%
Dividend Yield
2.32%
Payout Ratio
47.7%
How CCEP Splits Its Return
Div 2.32%
Buyback 2.7%
Dividend 2.32%Buybacks 2.7%
Dividend Profile
Yield, cadence, and growth quality
Dividend / Share
Trailing annualized cash dividend
$1.95
Growth Streak
Consecutive years of dividend increases
5Y
3Y Div CAGR
11.1%
5Y Div CAGR
18.4%
Ex-Dividend Date
—
Payment Cadence
Semi-Annual
2 payments over the last 12 months
Buyback Engine
How much per-share support comes from repurchases
Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$1.0B
Estimated Shares Retired
10M
Approx. Share Reduction
2.3%
Shares Outstanding
Current diluted share count from the screening snapshot
449M
At 2.3%/year, buybacks mechanically lift EPS even with flat earnings — each remaining share represents a slightly larger piece of the company.
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.95 | — | — | — |
| 2025 | $2.33 | +11.8% | 2.4% | 4.6% |
| 2024 | $2.09 | +5.9% | 0.0% | 2.6% |
| 2023 | $1.97 | +15.9% | 0.0% | 2.7% |
| 2022 | $1.70 | +4.9% | 0.0% | 3.0% |
FAQ
7 questionsCCEP Investor Questions
Common questions answered from live analyst data and company financials.
01Is Coca-Cola Europacific Partners PLC (CCEP) stock a buy or sell in 2026?
Coca-Cola Europacific Partners PLC (CCEP) is rated Buy by Wall Street analysts as of 2026. Of 28 analysts covering the stock, 15 rate it Buy or Strong Buy, 11 rate it Hold, and 2 rate it Sell or Strong Sell. The consensus 12-month price target is $111, implying +14.0% from the current price of $97. The bear case scenario is $103 and the bull case is $216.
02What is the CCEP stock price target for 2026?
The Wall Street consensus price target for CCEP is $111 based on 28 analyst estimates. The high-end target is $114 (+17.6% from today), and the low-end target is $108 (+11.4%). The base case model target is $164.
03Is Coca-Cola Europacific Partners PLC (CCEP) stock overvalued in 2026?
CCEP trades at 21.8x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals cheap versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
04What are the main risks for Coca-Cola Europacific Partners PLC (CCEP) stock in 2026?
The primary risks for CCEP in 2026 are: (1) Forward-looking statement risks — Financial projections and strategic objectives are subject to uncertainties, including mergers, acquisitions, and market conditions. (2) Revenue growth uncertainty — Revenue expansion of 3%-4% is contingent on premiumization and innovation, which may not materialize as expected. (3) Dependence on Coca-Cola partnership — Innovation pipelines and growth heavily rely on the partnership with The Coca-Cola Company, introducing dependency risks. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
05What is Coca-Cola Europacific Partners PLC's revenue and earnings forecast?
Analyst consensus estimates CCEP will report consensus revenue of $42.7B (+3.5% year-over-year) and EPS of $7.36 (-1.4% year-over-year) for the upcoming fiscal year. The following year, analysts project $44.0B in revenue.
06When does Coca-Cola Europacific Partners PLC (CCEP) report its next earnings?
Coca-Cola Europacific Partners PLC is expected to report its next earnings on approximately 2026-08-04. Consensus expects EPS of $2.46 and revenue of $12.3B. Over recent quarters, CCEP has beaten EPS estimates 75% of the time.
07How much free cash flow does Coca-Cola Europacific Partners PLC generate?
Coca-Cola Europacific Partners PLC (CCEP) generated $4.4B in free cash flow over the trailing twelve months — a free cash flow margin of 10.7%. CCEP returns capital to shareholders through dividends (2.3% yield) and share repurchases ($1.0B TTM).